Three-Year Outcomes of Aflibercept Treatment for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting

INTRODUCTION: To report 3-year treatment outcomes with intravitreal aflibercept injections for neovascular age-related macular degeneration (nAMD) in routine clinical practice. METHODS: This was a retrospective, single-centre, non-randomized interventional case series analysis. Data from treatment-n...

Descripción completa

Detalles Bibliográficos
Autores principales: Eleftheriadou, Maria, Gemenetzi, Maria, Lukic, Marko, Sivaprasad, Sobha, Hykin, Philip G., Hamilton, Robin D., Rajendram, Ranjan, Tufail, Adnan, Patel, Praveen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258584/
https://www.ncbi.nlm.nih.gov/pubmed/29982914
http://dx.doi.org/10.1007/s40123-018-0139-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6258584/
https://www.ncbi.nlm.nih.gov/pubmed/29982914
http://dx.doi.org/10.1007/s40123-018-0139-5

Ejemplares similares